Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who wrote (84)	2/4/1997 11:54:00 PM
From: James Silverman	of 1115

GILD's herpes drug Forvade is a topical gel version of an ALREADY approved drug given via IV for CMV retinitis. GILD may be trying to backdoor it through its indication for AIDS patients not responding to currently available treatments. Going over some LDAK stuff is quite interesting. What happened to all their European deals? What happened to their JV with Chiron, has that been silently dropped or are they still pursuing it? What happened to Lidakol's indications of Chicken Pox and Shingles? Additionally they made statements they were going to pursue it as a protective gel vs. AIDS. What are their targets for an NDA filing? Does Lidakol compare favaorably with Zovirax? What about all the cheap warrants that are out there, LDAK extended the conversion dates on them to Dec 31? How many shares and at what price do they convert to? Why did they extend the date?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next